Redefining Precision
at the Nanoscale
Empowering researchers with the new gold standard for nanoparticle analysis, bridging the gap between nanoparticle development and clinical reality.
Origin story
Born from the Lab,
Built for the Future.
The Spark
Our foundation is built on deep technical expertise. Prior to Vesiculate's inception, our founder, Ken, trained for over 13 years in nanoparticle research across Australia and Germany (notably as a Humboldt Fellow), where he established a track record of high-impact research.
However, he observed a persistent flaw in the field: findings were often overstated despite ambiguities in nanoparticle analysis. In a market flooded with dozens of nanoparticle analyzers, the lack of standardization meant instrument settings are often subjective. Whether stemming from disparate protocols or a misunderstanding of instrument limitations, this variability inevitably leads to inconsistent data. Ken realized this systemic gap didn't just affect academic literature—it directly undermines the potential of nanoparticles being clinically translated.
The Innovation
Vesiculate was created to close that gap. We recognized that the industry didn't just need new nanoparticles; it needed reliable benchmarks to validate measurement accuracy. We are therefore devoted to engineering reference standards designed to unlock the analytical performance of modern nanoparticle analyzers. Our reference standards remove ambiguity from analytical workflows, facilitating data standardization and the quantitative rigor required to validate findings across different instruments and labs.
The Mission
Our mission is to become the definitive source for nanoparticle reference materials. We aim to establish the universal benchmark that researchers turn to for data integrity. By eliminating analytical ambiguity, we accelerate the path to clinical translation, ensuring that future technologies are built on a foundation of proof.
About Vesiculate
Based in Sydney, Australia, Vesiculate operates across two innovation hubs. Our lab operations are headquartered at the Australian Genome Foundry (AGF) at Macquarie University, while we also maintain commercial residency within UNSW Founders at UNSW Sydney following our earlier participation in their flagship 10x Accelerator program. We are also proudly supported by Bioplatforms Australia.
Founder Profile
Vesiculate is the brainchild of Dr. Chin Ken Wong, a researcher with over a decade of hands-on experience engineering nanoparticles. From lipids and polymers to inorganics, coacervates, and hybrids—if it’s a nanoparticle, he's likely made it!
Ken's expertise spans from fundamental 'blue skies' research to materials science and biological applications. He holds a PhD in Chemistry and has a proven track record publishing in top-tier interdisciplinary journals including Nat. Commun., JACS, Angew. Chem., ACS Nano, Chem. Soc. Rev., and more.
Ken maintains his ties to the research community as an Adjunct Lecturer at UNSW Sydney.
Our Validation Platform
Our commitment to data integrity is grounded in complete vertical integration. Unlike nanoparticle suppliers who rely on third-party white-labeling, Vesiculate designs, synthesizes, and validates every product in-house.
This hands-on approach allows us to maintain rigorous quality standards and rapidly troubleshoot complex analytical challenges. Because we are experts in both synthesis and analysis, we offer the technical depth and customization capabilities necessary to partner with researchers on novel solutions.
We are not just distributors of standards; we are the engineers behind them.
Synthesis & Facilities
-
Access to chemistry and PC2 lab facilities
-
Nanoparticle synthesis platform (vesicles, micelles, microparticles, beads, etc.)
High-Resolution Imaging
-
Transmission electron microscopy (TEM)
-
Scanning electron microscopy (SEM)
-
Cryogenic electron microscopy (Cryo-EM)
-
Cryo-tomography (Cryo-ET)
Particle Analysis
-
Dynamic light scattering (DLS)
-
Multi-angle DLS (MADLS)
-
Nanoparticle tracking analysis (NTA)
-
Conventional flow cytometry (FCM)
-
Single-particle flow cytometry (nFCM/nanoFCM)
-
Electrophoretic potential (Zeta potential)
-
Spectroscopy (UV-Vis, fluorescence, plate reader)
Our Locations
Contact Us
Have questions or need further technical details? Please reach out to us using this form.
We welcome all discussions.